Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that the cornea has two types of stem cells, with Lrig1+ cells being key for renewal in aging corneas, independent of CD44.

The assay effectively identifies compounds that affect immune cell activation.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

Stem cell behavior varies with stimuli, and lineage changes can happen without affecting stem cell division.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

The nail immune system is similar to hair but different from skin, with fewer immune markers.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

The conclusion is that CD90 is not a specific marker for fibroblast subtypes and better methods are needed to identify them.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

Older mice healed wounds better but lost more weight and might have weaker immune systems afterward.

IL-1 and IL-7 help activate cells that boost hair follicle stem cell growth, aiding wound healing.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

ABCG2 protein marks stem-like skin cells in human epidermis.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.